Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (415) 476-5777 Click to print page  Print
Other options

view Contact Information


Contact Information for Tucatinib, Ibrance plus Femara in Advanced HR+, HER2+ Breast Cancer

The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org

University of Arizona, Tucson, AZ,  85724

Principal Investigator: Pavani Chalasani
Contact person: Dana Lewallen
Phone:520-626-2175
Email: DLewallen@uacc.arizona.edu

University of Colorado Denver, Aurora, CO,  80045

Principal Investigator: Elena Shagisultanova, MD, PhD
Contact person: Tiffany Colvin
Phone:720-848-0664
Email: tiffany.colvin@ucdenver.edu

Northwestern University, Chicago, IL,  60611

Principal Investigator: William Gradishar
Contact person: Peggy Gilbertsen
Phone:312-695-1102
Email: cancertrials@northwestern.edu

New Mexico Cancer Care Alliance, Albuquerque, NM,  87131

Principal Investigator: Ursa Brown-Glaberman
Contact person: Karwyn Gustafson
Phone:505-925-0380
Email: KSGustafson@salud.unm.edu

Stony Brook University, Stony Brook, NY,  11794

Principal Investigator: Alison Stopeck
Contact person: Pushpa Talanki
Phone:631-638-0815
Email: Pushpa.talanki@stonybrookmedicine.edu

University of Texas Health Science Center San Antonio, San Antonio, TX,  78229

Principal Investigator: Andrew Brenner
Contact person: CTRC
Phone:210-450-5798
Email: CTRCReferral@uthscsa.edu